6/23
04:01 pm
atha
Athira Pharma downgraded at JMP after Alzheimer’s setback [Seeking Alpha]
Neutral
Report
Athira Pharma downgraded at JMP after Alzheimer’s setback [Seeking Alpha]
6/23
08:46 am
atha
Athira Pharma, Inc. (
NASDAQ: ATHA ) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.
Low
Report
Athira Pharma, Inc. (
NASDAQ: ATHA ) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.
6/23
07:14 am
atha
Athira Pharma, Inc. (
NASDAQ: ATHA ) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
Low
Report
Athira Pharma, Inc. (
NASDAQ: ATHA ) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
6/22
07:18 pm
atha
Athira Pharma, Inc. (
NASDAQ: ATHA ) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.
Medium
Report
Athira Pharma, Inc. (
NASDAQ: ATHA ) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.
6/22
02:01 pm
atha
Athira Pharma: The Market Is Missing A Potential New Alzheimer's Drug [Seeking Alpha]
Low
Report
Athira Pharma: The Market Is Missing A Potential New Alzheimer's Drug [Seeking Alpha]
6/22
08:01 am
atha
Athira Pharma crashes 67% as lead asset fails in Alzheimer’s trial [Seeking Alpha]
Medium
Report
Athira Pharma crashes 67% as lead asset fails in Alzheimer’s trial [Seeking Alpha]
6/22
07:00 am
atha
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
High
Report
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
6/7
07:00 am
atha
Athira Pharma Announces Formation of Scientific Advisory Board Comprised of Renowned Leaders in Neurology Research
Low
Report
Athira Pharma Announces Formation of Scientific Advisory Board Comprised of Renowned Leaders in Neurology Research
5/12/2022
04:05 pm
atha
athira pharma, inc.
BEAT
Report
4.0%
athira pharma, inc.
11/10/2021
04:05 pm
atha
athira pharma, inc.
BEAT
Report
10.3%
athira pharma, inc.
8/16/2021
04:01 pm
atha
athira pharma, inc.
MISS
Report
-4.1%
athira pharma, inc.
6/24
07:55 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: Worthington Mark
Neutral
Report
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: Worthington Mark
6/24
07:54 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: MOEBIUS HANS
Neutral
Report
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: MOEBIUS HANS
6/24
07:53 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: MILESON GLENNA
Neutral
Report
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: MILESON GLENNA
6/24
07:52 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: Litton Mark James
Neutral
Report
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: Litton Mark James
6/24
07:51 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: Lenington Rachel
Neutral
Report
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: Lenington Rachel
6/24
07:25 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: CHURCH KEVIN
Neutral
Report
Form 4 Athira Pharma, Inc. For: Jun 22 Filed by: CHURCH KEVIN
6/22
07:06 am
atha
Form 8-K Athira Pharma, Inc. For: Jun 22
High
Report
Form 8-K Athira Pharma, Inc. For: Jun 22
6/10
05:53 pm
atha
Form 4 Athira Pharma, Inc. For: Jun 08 Filed by: CHURCH KEVIN
Low
Report
Form 4 Athira Pharma, Inc. For: Jun 08 Filed by: CHURCH KEVIN
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register